Price range: $60.00 through $85.00
Compound: BPC-157 / TB-500 Peptide Blend
Amount: 10mg or 20mg per vial, depending on the selected option
Format: Lyophilized Powder
Chemical Classification: Two-Component Peptide Research Blend
Composition: 10mg option: BPC-157 5mg + TB-500 5mg; 20mg option: BPC-157 10mg + TB-500 10mg
Chemical Profile: The BPC-157 / TB-500 Peptide Blend is a 1:1 research blend of BPC-157 and TB-500. BPC-157 is a 15-residue synthetic peptide; TB-500 is associated with thymosin beta-4-related research materials. The ingredients have distinct scientific backgrounds, and published results about either ingredient alone do not establish the properties of the complete mixture.
Research Use Only. Not for human or veterinary use.
Subscription of three vials for a total of 30mg/30mg is now $200.
The BPC-157 / TB-500 Peptide Blend is a two-component research product containing BPC-157 and TB-500 in equal listed amounts. It is a mixture rather than a distinct single molecular entity.
Because the blend contains two substances, it does not have one amino-acid sequence, molecular formula or single-compound CAS identifier. The components should be described separately.
The mixture is offered in two sizes with the same listed ratio.
| Specification | 10mg Option | 20mg Option |
|---|---|---|
| Product Name | BPC-157 / TB-500 Peptide Blend | BPC-157 / TB-500 Peptide Blend |
| Component 1 | BPC-157 | BPC-157 |
| Component 2 | TB-500 | TB-500 |
| BPC-157 Amount | 5mg | 10mg |
| TB-500 Amount | 5mg | 10mg |
| Total | 10mg | 20mg |
| Component Ratio | 1:1 by mass | 1:1 by mass |
| Form | Lyophilized Powder | Lyophilized Powder |
| Intended Use | Laboratory Research Only | Laboratory Research Only |
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, consisting of 15 amino-acid residues. Its published research focuses largely on experimental cell models and other preclinical systems.
TB-500 is a research product name associated with thymosin beta-4-related peptides. Literature on thymosin beta-4 discusses actin binding, cytoskeletal regulation and cellular movement.
A mixture combines the separate compounds in one vial. The experimental properties of an individual ingredient may not predict the behavior of the formulation as a whole.
In addition, the TB-500 name is used for more than one thymosin beta-4-related preparation. Findings about full-length thymosin beta-4 or a peptide fragment should be distinguished when interpreting a specific TB-500-related research material.
The BPC-157 / TB-500 Peptide Blend contains two peptide-related research materials, BPC-157 and TB-500. Each has a different molecular identity and published research history.
A defined mixture can be described by its composition and total amount. However, combining two ingredients does not automatically establish a synergistic biological effect or recreate the findings from separate experiments.
BPC-157 is a 15-amino-acid peptide discussed in primarily preclinical investigations involving cell signaling and experimental tissue models.
Some published experiments have examined endothelial-cell behavior and pathways involving nitric oxide or vascular-associated signaling. These findings describe studies of BPC-157 as an individual compound and do not demonstrate a specific outcome for the complete blend.
TB-500 is associated with research on thymosin beta-4 and related peptide materials. Thymosin beta-4 is known for its interaction with monomeric actin (G-actin).
Actin-binding studies examine biochemical interactions related to cytoskeletal dynamics. The literature includes experiments on the full-length 43-residue peptide and investigations of fragments.
Results depend on the exact molecular material used and cannot automatically be transferred between preparations with different sequences.
Cell movement involves rearrangement of actin filaments and related cellular structures. Thymosin beta-4 research provides a molecular framework for examining these processes in controlled models.
BPC-157’s research literature involves a separate set of peptide and cellular pathways. These two scientific backgrounds may be discussed alongside one another, but joint effects require studies of the combined formulation itself.
The BPC-157 / TB-500 Peptide Blend is listed as a 1:1 mixture by mass, with either 5mg of each component or 10mg of each component per vial.
This composition makes the two product sizes comparable in their listed ingredient proportions. Equal mass is not the same as equal molecule count, because the chemical species can differ in molecular weight.
The published literature is substantially more developed for individual BPC-157 studies and thymosin beta-4-related experiments than for this exact mixed product.
Certificates of Analysis (COAs) are posted on the product page when available. To request documentation for a specific lot, contact the Genoscience team with the lot number.
Store unopened lyophilized research material at −20 °C, protected from direct light and moisture. Allow the sealed vial to reach room temperature before opening to reduce condensation.
Use suitable laboratory protective equipment and standard research-facility procedures.
Research Use Only: This blend is intended strictly for laboratory research and development.
Not for Human or Veterinary Use: Not intended for human consumption, administration or veterinary applications.
Not an Approved Medicine: This mixture is not marketed as an FDA-approved drug or treatment.
Research Limitations: Studies of BPC-157 or thymosin beta-4-related materials individually do not establish the safety, efficacy or biological behavior of their combination.
The BPC-157 / TB-500 Peptide Blend is a research blend containing BPC-157 and TB-500 in equal listed mass amounts.
The 10mg option contains 5mg BPC-157 and 5mg TB-500. The 20mg option contains 10mg of each component.
No. It is a two-component mixture and does not represent one single amino-acid sequence.
GLOW contains BPC-157 and TB-500 along with GHK-Cu. The BPC-157 / TB-500 Peptide Blend contains only BPC-157 and TB-500.
No. The ingredients have different research backgrounds, and the exact combined formulation requires its own studies before any joint effect can be established.
When available, the COA for BPC-157 / TB-500 Peptide Blend can be found on the product page. You may also contact Genoscience to request a COA or ask about documentation availability for a specific lot.
No. This Genoscience product is sold strictly for laboratory research and is not intended for human or veterinary use.
Original price was: $60.00.$40.00Current price is: $40.00.
Original price was: $100.00.$60.00Current price is: $60.00.
Original price was: $150.00.$70.00Current price is: $70.00.
Original price was: $80.00.$50.00Current price is: $50.00.
You must be at least 21 years old to enter Genoscience and review products intended for laboratory research use only.
Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
